Cempra Pharmaceuticals announces schedule of poster presentations in ECCMID 2010 Cempra Pharmaceuticals today announced its plan of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease in Vienna, Austria, on 10-13 April, 2010 generic pills . One poster will show Phase 1 multi-dose scientific results for CEM-101, a next-generation oral and intravenous macrolide.S. For acute bacterial pores and skin structure infections having a proprietary front-loading oral dosing regimen.m.

This appropriate limit is founded on experiments executed in the 1980s. However, consumer organizations and researchers point out that contact with lower dosages has since been linked to a variety of health problems, including reproductive abnormalities, increased risk of prostate and breast cancers, heart and diabetes disease. Mr.?.. Cereplast confirms that its resins are created without the use of BPA Cereplast, Inc. , a leading manufacturer of proprietary bio-based, sustainable plastics, confirmed today that its resins are made without the usage of Bisphenol A, known as BPA commonly.